Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study

Author： Campiglio Manuela   Bufalino Rosaria   Sandri Marco   Ferri Elisa   Aiello Rosa   Matteis Andrea   Mottolese Marcella   Placido Sabino   Querzoli Patrizia   Jirillo Antonio   Bottini Alberto   Fantini Manuela   Bonetti Andrea   Pedani Fulvia   Mauri Maria   Molino Annamaria   Ferro Antonella   Pupa Serenella   Sasso Marianna   Ménard Sylvie   Balsari Andrea   Tagliabue Elda  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.128, Iss.1, 2011-07, pp. : 147-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

By Nakamura Seigo  

Breast Cancer, Vol. 17, Iss. 3, 2010-07 ,pp. : 199-204

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia   Pronzato Paolo   Del Mastro Lucia  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite

Infused Therapy and Survival in Older Patients Diagnosed with Metastatic Breast Cancer who Received Trastuzumab

By Griffiths Robert I.   Lalla Deepa   Herbert Robert J.   Doan Justin F.   Brammer Melissa G.   Danese Mark D.  

Cancer Investigation, Vol. 29, Iss. 9, 2011-10 ,pp. : 573-584

Informa Healthcare

Access to resources Recommend Favorite

Phospho-PRAS40Thr246 predicts trastuzumab response in patients with HER2-positive metastatic breast cancer

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 785-789

Spandidos Publications

Access to resources Recommend Favorite

Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials

By Blum Joanne   Kohles Joseph   McKenna Edward   Scotto Nana   Hu Sylvia   Odom Dawn   Kaye James   Glück Stefan  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 431-439

Springer Publishing Company

Access to resources Recommend Favorite